PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Design and Evolution: Molecular Sleuthing Reveals Drug Selectivity
June 2015
Families in Gene Neighborhoods
June 2015
Ryanodine Receptor
April 2015
CCR5 and HIV Infection
January 2015
Drug Targets: Bile Acids in Motion
September 2014
Drug Targets: S1R's Ligands and Partners
September 2014
P2Y Receptors and Blood Clotting
September 2014
Bacterial CDI Toxins
June 2014
Glucagon Receptor
April 2014
Viroporins
March 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Design and Discovery: Virtual Drug Screening
January 2014
Cancer Networks: IFI16-mediated p53 Activation
November 2013
G Proteins and Cancer
November 2013
Drug Discovery: Antidepressant Potential of 6-NQ SERT Inhibitors
October 2013
Drug Discovery: Finding Druggable Targets
October 2013
Drug Discovery: Identifying Dynamic Networks by CONTACT
October 2013
Drug Discovery: Modeling NET Interactions
October 2013
Membrane Proteome: GPCR Substrate Recognition and Functional Selectivity
August 2013
Infectious Diseases: Determining the Essential Structome
May 2013
NDM-1 and Antibiotics
May 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Cytochrome Oxidase
November 2012
Membrane Proteome: The ABCs of Transport
November 2012
Bacterial Phosphotransferase System
October 2012
Regulatory insights
September 2012
Solute Channels
September 2012
Pocket changes
July 2012
Receptor bias
July 2012
Anthrax Stealth Siderophores
June 2012
G Protein-Coupled Receptors
May 2012
Substrate specificity sleuths
April 2012
Reading out regioselectivity
December 2011
Superbugs and Antibiotic Resistance
December 2011
Terminal activation
December 2011
A change to resistance
November 2011
Docking and rolling
October 2011
Breaking down the defenses
September 2011
A2A Adenosine Receptor
May 2011
Cell wall recycler
May 2011
Subtly different
March 2011
CXCR4
January 2011
Subtle shifts
January 2011
ABA receptor diversity
November 2010
COX inhibition: Naproxen by proxy
November 2010
Zinc Transporter ZntB
July 2010
Peptidoglycan binding: Calcium-free killing
June 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Antibiotics and Ribosome Function
March 2010
Safer Alzheimer's drugs?
March 2010
Anthrax evasion tactics
September 2009
GPCR subunits: Separate but not equal
September 2009
Antibiotic target
August 2009
Salicylic Acid Binding Protein 2
August 2009
Lysostaphin
July 2009
Tackling influenza
June 2009
Bacterial Leucine Transporter, LeuT
May 2009
Anthrax stealth molecule
March 2009
Drug targets to aim for
February 2009
High-energy storage system
February 2009
Transporter mechanism in sight
February 2009
Scavenger Decapping Enzyme DcpS
November 2008
Blocking AmtB
September 2008

Research Themes Drug discovery

Salicylic Acid Binding Protein 2

PSI-SGKB [doi:10.3942/psi_sgkb/fm_2009_8]
Featured System - August 2009
Short description: Centuries ago, both the ancient Greeks and native Americans discovered that willow bark and other plants can dull pain.

Centuries ago, both the ancient Greeks and native Americans discovered that willow bark and other plants can dull pain. By analyzing these traditional cures, scientists in the nineteenth century extracted the active molecule, salicylic acid, and developed a modified molecule with better drug properties, acetylsalicylic acid or aspirin. In our bodies, aspirin blocks an enzyme that builds one of the molecules of pain signaling. Plants, on the other hand, use salicylic acid for an entirely different type of signaling.

Defensive Action

Plants have developed a complex and multi-layered system to protect themselves from attack by bacteria and viruses. When a leaf gets infected, for instance by tobacco mosaic virus, the local cells make the ultimate sacrifice, inducing a form of programmed cell death. This helps control the spread of the virus by proactively removing all infectable cells in the neighborhood. At the same time, the plant launches a more systemic defense. It sends a signal to all of its distant parts, telling them to build defensive proteins and ready themselves for attack. These defenses are costly, and may result in stunted growth, but this is better than completely losing the battle against the attacker.

Aromatic Signals

Methyl salicylate, the methyl ester of salicylic acid, is one of the signals that spreads through plants, readying them for attack. Methyl salicylate is a familiar molecule, since it provides the distinctive taste and smell of wintergreen flavorings. It is used as a neutral messenger, which is created by cells under attack and delivered to cells throughout the plant. Then, the enzyme SABP2 (salicylic acid binding protein 2) takes methyl salicylate and cleaves off the methyl group, releasing active salicylic acid, which then stimulates the production of defensive proteins in the target cells.

SABP2 in Action

SABP2 was originally discovered based on its ability to bind to salicylic acid (hence its name), but the recent structure of the protein solved by researchers at the NESG revealed its role in cleavage of methyl salicylate and inhibition of the reaction by the product, salicylic acid. The structure, available in PDB entry 1y7i, shows that SABP2 is one of a class of alpha/beta hydrolase enzymes that cleave small esters and other molecules. The active site completely surrounds the molecule, recognizing both the distinctive aromatic ring and the acidic group. A catalytic triad reminiscent of the digestive serine proteases performs the cleavage reaction. Based on this structure, researchers have designed analogues of salicylic acid to probe signaling methods in other plants. To explore this structure in more detail, you can click on the image below for an interactive Jmol view of the active site.

The JSmol tab below displays an interactive JSmol.

Guanine Nucleotide Exchange Factor Vav1 and Rho GTPase Rac1 (PDB entry 3bji)

Vav1 (in blue and green) interacts with two key switch loops in Rac1 (the switch loops are colored bright red in this representation). The typical interaction between guanine nucleotide exchange factors and GTPases involves other regions of the GTPase, but since the Vav1 structure is stabilized by the small cysteine-rich domain (colored green here, with two zinc ions in magenta), it can focus its attention on the switch loops. This makes Vav1 more promiscuous than other guanine exchange factors.

References

  1. Forouhar, F., Yang, Y., Kumar, D., Chen, Y., Fridman, E., Park, S. W., Chiang, Y., Acton, T. B., Montelione, G. T., Pichersky, E., Klessig, D. F. and Tong, L. (2005) Structural and biochemical studies identify tobacco SABP2 as a methyl salicylate esterase and implicate it in plant innate immunity. PNAS 102, 1773-1778.

  2. Park, S. W., Liu, P. P., Forouhar, F., Vlot, A. C., Tong, L., Tietjen, K. and Klessig, D. F. (2009) Use of a synthetic salicylic acid analog to investigate the roles of methyl salicylate and its esterases in plant disease resistance. J. Biol. Chem. 284, 7307-7317.

  3. Park, S. W., Kaimoyo, E., Kumar, D., Mosher, S. and Klessig, D. F. (2007) Methyl salicylate is a critical mobile signal for plant systemic acquired resistance. Science 318, 113-116.

  4. Loake, G. and Grant, M. (2007) Salicylic acid in plant defence--the players and protagonists. Curr. Op. Plant Biol. 10, 456-472.

  5. Durrant, W. E. and Dong, X. (2004) System acquired resistance. Annu. Rev. Phytopathol. 42, 185-209.

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health